TUESDAY, May 13, 2025 (HealthDay News) — U.S. health officials are telling travelers aged 60 and older to avoid a chikungunya ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

A total of 19,901 dengue cases have been reported in the country so far this year, according to the National Dengue Control ...

FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...

The government of the United States has now advised its travelers who are of 60 years and above to not get a chikungunya ...

Chikungunya is a viral disease that typically spreads during the monsoon Maharashtra is witnessing a sharp rise in Chikungunya cases, even before the onset of monsoon. According to the National ...

On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of Valneva’s chikungunya vaccine in older adults. The FDA and the ...

May 7 (Reuters) - The European Union's health regulator said on Wednesday it was reviewing French drugmaker Valneva's (VLS.PA), opens new tab chikungunya vaccine after reports of serious side ...

Pune: There were concerning complications seen in children during last year's chikungunya outbreak, including one case which may be the first documented instance of a patient needing a new liver ...